EU Commission to end AstraZeneca and J&J vaccine contracts at expiry - paper


  • World
  • Wednesday, 14 Apr 2021

FILE PHOTO: A medical worker prepares a dose of Oxford/AstraZeneca's COVID-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman

MILAN (Reuters) - The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca and Johnson & Johnson (J&J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.

"The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry," the newspaper reported.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

'Lucky to have him': Australia mourns refugee guard killed in Bondi attack
Trump ready to renew conservative alliance with Hungary's Orban
Kenya Airways accuses Congo of harassment over detained staff
Inside Big Tech’s underground race to buy AI training data
Ireland says UK's Rwanda policy drives migrants over its border
Somalia detains U.S.-trained commandos over theft of rations
A Chinese firm is America’s favourite drone maker – except in Washington
Smaller towns in South Korea bear brunt of doctors’ shortage
Spain to send Patriot missiles to Ukraine, El Pais reports
Swiss parliamentary committee backs $5.5 billion aid plan for Ukraine

Others Also Read